GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings. However, over the past few years, these medications have become popular due to ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s Trulicity can cause cancer of the thyroid. Six months ago, the Pharmacovigilance Risk ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Medscape Medical News, November 14, 2024 GLP-1 Prescribing Decisions ... 2024 ATA 2024 Managing Long-Term Health Risks in Thyroid Cancer Survivors ATA 2024 spotlighted new research to help ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

"This isn't sci-fi. It's just we aren't there yet." -- Adam Rodman, MD, MPH, director of artificial intelligence (AI) ...

Nearly 60% of women dismiss their symptoms until it disrupts their daily life — this doctor is asking them to trust their ...

“Most people have understood Ozempic as kind of a catch-all for the GLP-1 class of medications ... and Wegovy include possible thyroid tumors, including cancer; pancreatitis, vision changes ...

HealthDay News — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without ...